Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach

References

• Darnell JE Jr. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002;2:740−9
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630−5
   PubMed Web of Science ®Google Scholar
• Turkson J, Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000;19:6613−26
   PubMed Web of Science ®Google Scholar
• Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000;19:2468−73
   PubMed Web of Science ®Google Scholar
• Turkson J. STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets 2004;8:409–22
   PubMed Web of Science ®Google Scholar
• Masciocchi D, Gelain A, Villa S, et al. Signal Transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy. Future Med Chem 2011;3:367–97
   PubMed Web of Science ®Google Scholar
• Debnath B, Xu S, Neamati, N. Small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) protein. J Med Chem 2012;55:6645−68
   PubMed Web of Science ®Google Scholar
• Costantino L, Barlocco D. STAT3 as a target for cancer drug discovery. Curr Med Chem 2008;15:834–43
   PubMed Web of Science ®Google Scholar
• Song H, Wang R, Wang S, Lin J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci USA 2005;102:4700−5
   PubMed Web of Science ®Google Scholar
• Siddiquee K, Zhang S, Guida WC, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007;104:7391−6
   PubMed Web of Science ®Google Scholar
• Matsuno K, Masuda Y, Uehara Y, et al. Identification of a new series of Stat3 inhibitors by virtual screening. ACS Med Chem Lett 2010;1:371−5
   PubMed Web of Science ®Google Scholar
• Hao W, Hu Y, Niu C, et al. Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening. Bioorg Med Chem Lett 2008;18:4988–92
   PubMed Web of Science ®Google Scholar
• Xu X, Kasembeli MM, Jiang X, et al. Chemical probes that competitively and selectively inhibit Stat3 activation. PLoS One 2009;4:e4783–94
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu W, Li Y. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening. Eur J Med Chem 2013;62:301–10
   PubMed Web of Science ®Google Scholar
• Liu LJ, Leung KH, Chan DS, et al. Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening. Cell Death Dis 2014;5:e1293–302
   PubMed Web of Science ®Google Scholar
• Chen H, Yang Z, Ding C, et al. Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy. Eur J Med Chem 2013;62:498–507
   PubMed Web of Science ®Google Scholar
• Yu W, Xiao H, Lin J, Li C. Discovery of Novel STAT3 Small molecule inhibitors via in silico site-directed fragment-based drug design. J Med Chem 2013;56:4402−12
   PubMedGoogle Scholar
• Shahani, VM, Yue P, Haftchenary S, et al. Identification of purine-scaffold small-molecule inhibitors of stat3 activation by QSAR studies. ACS Med Chem Lett 2011;2:79–84
   PubMed Web of Science ®Google Scholar
• Leung KH, Liu LJ, Lin S, et al. Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening. Methods 2015;71:38–43
   PubMed Web of Science ®Google Scholar
• Becker S, Groner B, Muller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998;394:145−51
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res 2000;28:235–42
   PubMed Web of Science ®Google Scholar
• PHASE, version 3.1. New York (NY): Schrödinger LLC; 2009
   Google Scholar
• GLIDE, version 5.0. Portland (OR): Schrödinger Inc; 2009
   Google Scholar
• Sanner MF. Python: a programming language for software integration and development. J Mol Graph Model 1999;17:57–61
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91
   PubMed Web of Science ®Google Scholar
• Case DA, Darden TA, Cheatham III TE, et al. AMBER, version 11. San Francisco (CA): University of California; 2010
   Google Scholar
• Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779–815
   PubMed Web of Science ®Google Scholar
• York DM, Darden TA, Pedersen LG. The effect of long-range electrostatic interactions in simulations of macromolecular crystals – a comparison of the Ewald and truncated list methods. J Chem Phys 1993;99:8345–8
   Web of Science ®Google Scholar
• Masciocchi D, Villa S, Meneghetti F, et al. Biological and computational evaluation of an oxadiazole derivative (MD77) as a new lead for direct STAT3 inhibitors. Med Chem Commun 2012;3:592–9
   Web of Science ®Google Scholar
• Uehara Y, Mochizuki M, Matsuno K, et al. Novel high-throughput screening system for identifying STAT3-SH2 antagonist. Biochem Biophys Res Commun 2009;380:627–31
   PubMed Web of Science ®Google Scholar
• Turkson J, Ryan D, Kim JS, et al. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 2001;276:45443–55
   PubMed Web of Science ®Google Scholar
• Tuccinardi T, Poli G, Romboli V, et al. Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies. J Chem Inf Model 2014;54:2980−6
   PubMed Web of Science ®Google Scholar
• Tuccinardi T, Poli G, Dell'Agnello M, et al. Receptor-based virtual screening evaluation for the identification of estrogen receptor β ligands. J Enzyme Inhib Med Chem 2015;30:662−70
   PubMed Web of Science ®Google Scholar
• Poli G, Giuntini N, Martinelli A, Tuccinardi T. Application of a FLAP-consensus docking mixed strategy for the identification of new fatty acid amide hydrolase inhibitors. J Chem Inf Model 2015;55:667–75
   PubMed Web of Science ®Google Scholar